ReviewFrontiers in immunology2022

Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation.

Jes M Sanders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.